STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Medical Devices

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

byLiliana Vida
August 7, 2025
in Medical Devices, Mid-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Next-Gen BVA Device Promises Faster, More Accurate Fluid Management for Millions of Patients

Daxor Corporation (DXR), a global leader in blood volume measurement, has received FDA 510(k) clearance for its new rapid, compact, handheld Blood Volume Analyzer (BVA), marking a significant advancement in patient-specific fluid management. Designed for both hospital and outpatient settings, this lab-based device quantifies blood volume with high precision, addressing a longstanding gap in clinical care.

“For decades, clinicians have relied on imprecise or invasive methods to estimate blood volume,” said Michael Feldschuh, Daxor’s President and CEO. “Our new device revolutionizes care by providing fast, accurate data wherever a lab is available.”

Blood volume derangement contributes to a wide array of conditions—heart failure, sepsis, trauma, dialysis, and surgery—costing billions annually. With 7+ million heart failure patients and over 7 million critical care admissions each year, accurate volume measurement is essential.

Using the gold standard tracer dilution technique, BVA™ offers laboratory-grade accuracy in just one-third the time of its predecessor. Weighing only 7 pounds, it enables rapid deployment in resource-limited settings and delivers critical data to avoid both hypovolemia and hypervolemia complications.

Dr. John L. Jefferies, Daxor’s Chief Medical Officer, highlighted its clinical impact: “BVA-guided care has shown up to 86% reduction in heart failure mortality and 56% fewer readmissions in peer-reviewed studies.”

Developed with the U.S. Department of Defense, the device is backed by research from Duke, the Mayo Clinic, and the Cleveland Clinic. With over 75,000 tests shipped and five decades of research, Daxor is setting a new standard in precision diagnostics—empowering clinicians across cardiology, nephrology, emergency care, and beyond to deliver better, data-driven outcomes.

You might like this article:Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

Tags: DXRGrowthMoversNewsStock Market
Previous Post

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

Next Post

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

Related Posts

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

byLuca Blaumann
August 5, 2025
0

Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock...

evtol

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

byLiliana Vida
August 4, 2025
0

Electric air taxi pioneer Joby expands passenger operations as Blade spins off medical transport arm into new public company Blade...

investing

GoPro and Krispy Kreme Surge as Meme Stock Frenzy Reignites

byLuca Blaumann
July 23, 2025
0

Retail traders push small caps higher despite shaky fundamentals A fresh wave of meme stock mania swept through markets on...

Next Post

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Based on Your Interest

tesla
Artificial Intelligence

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

August 4, 2025
evtol
Aerospace & Defense

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

August 4, 2025
trading-chart-2
Large-Cap

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

July 30, 2025

Recommended

Aerospace & Defense

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
Ecommerece

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
Entertainment

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

July 25, 2025
Aerospace & Defense

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

July 24, 2025
Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
Stoxpo

Follow us on social media:

Highlights

  • Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock
  • Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light
  • Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations
  • Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
  • Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

August 7, 2025

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

August 7, 2025

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

August 6, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?